iShares Health Innovation Active ETF (BMED)

Assets	$10.12M
Expense Ratio	0.55%
PE Ratio	27.35
Shares Out	360,000
Dividend (ttm)	n/a
Dividend Yield	n/a
Ex-Dividend Date	n/a
Payout Frequency	n/a
Payout Ratio	n/a

Volume	1
Open	28.17
Previous Close	28.12
Day's Range	28.12 - 28.48
52-Week Low	n/a
52-Week High	n/a
Beta	0.83
Holdings	55
Inception Date	Sep 29, 2020

About BMED

Fund Home Page

The iShares Health Innovation Active ETF (BMED) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed to invest in global equities in the health sciences industry. BMED was launched on Sep 29, 2020 and is issued by BlackRock.

• Asset Class: Equity
• Category: Health
• Stock Exchange: NYSEARCA
• Ticker Symbol: BMED
• ETF Provider: BlackRock

Top 10 Holdings

44.67% of assets

Name	Symbol	Weight
Johnson & Johnson	JNJ	7.91%
Amgen Inc.	AMGN	4.66%
Edwards Lifesciences Corporation	EW	4.57%
Merck & Co., Inc.	MRK	4.56%
McKesson Corporation	MCK	4.52%
Cencora, Inc.	COR	4.44%
BLK CSH FND TREASURY SL AGENCY	XTSLA	4.33%
Gilead Sciences, Inc.	GILD	3.52%
WuXi Biologics (Cayman) Inc.	2269	3.22%
Moderna, Inc.	MRNA	2.93%

Performance

BMED had a total return of 12.40% in the past year, including dividends. Since the fund's inception, the average annual return has been 1.76%.